BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32554250)

  • 1. Chinese herbal medicine Baoyuan Jiedu decoction inhibits the accumulation of myeloid derived suppressor cells in pre-metastatic niche of lung via TGF-β/CCL9 pathway.
    Tian S; Song X; Wang Y; Wang X; Mou Y; Chen Q; Zhao H; Ma K; Wu Z; Yu H; Han X; Wang H; Wang S; Ji X; Zhang Y
    Biomed Pharmacother; 2020 Sep; 129():110380. PubMed ID: 32554250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
    Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
    Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.
    Yan HH; Jiang J; Pang Y; Achyut BR; Lizardo M; Liang X; Hunter K; Khanna C; Hollander C; Yang L
    Cancer Res; 2015 Dec; 75(24):5283-98. PubMed ID: 26483204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese Herbal Medicine Baoyuan Jiedu Decoction Inhibited Muscle Atrophy of Cancer Cachexia through Atrogin-l and MuRF-1.
    Zhang Y; Han X; Ouyang B; Wu Z; Yu H; Wang Y; Liu G; Ji X
    Evid Based Complement Alternat Med; 2017; 2017():6268378. PubMed ID: 28286533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ze-Qi-Tang Formula Induces Granulocytic Myeloid-Derived Suppressor Cell Apoptosis via STAT3/S100A9/Bcl-2/Caspase-3 Signaling to Prolong the Survival of Mice with Orthotopic Lung Cancer.
    Xu ZH; Zhu YZ; Su L; Tang XY; Yao C; Jiao XN; Hou YF; Chen X; Wei LY; Wang WT; Wang J; Gong CY; Zhu XD; Zhang F; Zhu SG; Zou CP
    Mediators Inflamm; 2021; 2021():8856326. PubMed ID: 33867859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
    Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
    Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis.
    Deng Z; Rong Y; Teng Y; Zhuang X; Samykutty A; Mu J; Zhang L; Cao P; Yan J; Miller D; Zhang HG
    Oncogene; 2017 Feb; 36(5):639-651. PubMed ID: 27345402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effect of Traditional Chinese Medicine Formula RP on Lung Microenvironment in Pre-Metastasis Stage of Breast Cancer.
    Ye Y; Pei L; Wu C; Liu S
    Integr Cancer Ther; 2019; 18():1534735419876341. PubMed ID: 31517546
    [No Abstract]   [Full Text] [Related]  

  • 11. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qiyusanlong decoction suppresses lung cancer in mice via Wnt/β-catenin pathway.
    Tong JB; Zhang XX; Wang XH; Zeng SJ; Wang DY; Zhang ZQ; Hu J; Yang C; Li ZG
    Mol Med Rep; 2018 Apr; 17(4):5320-5327. PubMed ID: 29393404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shuangshen granules attenuate lung metastasis by modulating bone marrow differentiation through mTOR signalling inhibition.
    Wei H; Guo C; Zhu R; Zhang C; Han N; Liu R; Hua B; Li Y; Lin H; Yu J
    J Ethnopharmacol; 2021 Dec; 281():113305. PubMed ID: 32890710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
    Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
    Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine (CQ) exerts anti-breast cancer through modulating microenvironment and inducing apoptosis.
    Zhang Y; Cao Y; Sun X; Feng Y; Du Y; Liu F; Yu C; Jin F
    Int Immunopharmacol; 2017 Jan; 42():100-107. PubMed ID: 27912145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Shugan Jianpi Formula () on myeloid-derived suppression cells-mediated depression breast cancer mice.
    Lu YT; Li J; Qi X; Pei YX; Shi WG; Lin HS
    Chin J Integr Med; 2017 Jun; 23(6):453-460. PubMed ID: 27796822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular endothelial growth factor secreted by breast cancer cells plays a critical role in the formation of pre-metastatic niche in the mouse lung].
    Li R; Yuan B; Zhang Y; Dai J; Zhang P; Fang F; Han M
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):17-22. PubMed ID: 26796801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.